HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
发明人:
Rifaat SAFADI
申请号：
US16407848
公开号：
US20190389948A1
申请日:
2019.05.09
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Method for treating, attenuating and/or preventing progression of a liver disorder in a subject, the method including administering a therapeutically effective amount of an agent capable of interfering with, inhibiting and/or preventing neuroligin 4 (NLGn4)-Neurexin 1-beta (Nrx1b) protein-protein interaction； and compositions including the agent.
